Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Other Accumulated Expenses (2024 - 2025)

Historic Other Accumulated Expenses for Coeptis Therapeutics Holdings (COEP) over the last 2 years, with Q3 2025 value amounting to $120000.0.

  • Coeptis Therapeutics Holdings' Other Accumulated Expenses changed N/A to $120000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $120000.0, marking a year-over-year change of. This contributed to the annual value of $235000.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Coeptis Therapeutics Holdings' Other Accumulated Expenses stood at $120000.0.
  • In the past 5 years, Coeptis Therapeutics Holdings' Other Accumulated Expenses ranged from a high of $235000.0 in Q4 2024 and a low of $120000.0 during Q3 2025